Cite
MLA Citation
F. Zammarchi et al.. “ADCT-502, a novel pyrrolobenzodiazepine (PBD)-based antibody–drug conjugate (ADC) targeting low HER2-expressing solid cancers.” European journal of cancer, vol. 69, n.d., pp. S28–. http://access.bl.uk/ark:/81055/vdc_100039473315.0x00002e